A3_tothemoon personal page - To The Moon

A3_tothemoon

A3_tothemoon

No personal profile

20Follow

3Followers

0Topic

0Badge

2021-09-02

$BlackBerry(BB)$Looking better by the day

2021-08-01

$BlackBerry(BB)$Should I cut my losses? Or should I HODL?

2021-07-17

$BlackBerry(BB)$Trust in BB!

2021-07-13

$Exela Technologies, Inc.(XELA)$Come on!

2021-07-10

$BlackBerry(BB)$Looking forward to coming months.

2021-07-09

$BlackBerry(BB)$It is just a temporary setback.

2021-06-20

like and comment pls. thank you

Sorry, the original content has been removed

2021-06-19

$BB Stock

2021-06-18

please like and comment. thank you

Orphazyme shares tumbled more than 60% in pre-market trading

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582539967940651","uuid":"3582539967940651","gmtCreate":1619445943805,"gmtModify":1624006942013,"name":"A3_tothemoon","pinyin":"a3tothemoona3tothemoon","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":20,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.23%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":812056632,"gmtCreate":1630542823926,"gmtModify":1676530334280,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Looking better by the day","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Looking better by the day","text":"$BlackBerry(BB)$Looking better by the day","images":[{"img":"https://static.tigerbbs.com/08bb7aa78f8844125c2cd636f7ecb967","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/812056632","isVote":1,"tweetType":1,"viewCount":832,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802467242,"gmtCreate":1627797385486,"gmtModify":1703496042250,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Should I cut my losses? Or should I HODL?&nbsp;","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Should I cut my losses? Or should I HODL?&nbsp;","text":"$BlackBerry(BB)$Should I cut my losses? Or should I HODL?","images":[{"img":"https://static.tigerbbs.com/ba6cc5f488f492c4049cd60142b7c017","width":"1170","height":"2260"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/802467242","isVote":1,"tweetType":1,"viewCount":814,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576094392273863","authorId":"3576094392273863","name":"Hengheng","avatar":"https://community-static.tradeup.com/news/3c7203a9a2725203dad785f749cf13c8","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3576094392273863","idStr":"3576094392273863"},"content":"hold it. add more when drop.. good prospect company.. salt fish has turn ard. buy for future.?","text":"hold it. add more when drop.. good prospect company.. salt fish has turn ard. buy for future.?","html":"hold it. add more when drop.. good prospect company.. salt fish has turn ard. buy for future.?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":179853472,"gmtCreate":1626506638696,"gmtModify":1703761285304,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Trust in BB!&nbsp;","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Trust in BB!&nbsp;","text":"$BlackBerry(BB)$Trust in BB!","images":[{"img":"https://static.tigerbbs.com/197ff3aed4d99406f11ec248b70372c2","width":"1170","height":"2260"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/179853472","isVote":1,"tweetType":1,"viewCount":636,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":145990195,"gmtCreate":1626185143717,"gmtModify":1703755078273,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>Come on!","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>Come on!","text":"$Exela Technologies, Inc.(XELA)$Come on!","images":[{"img":"https://static.tigerbbs.com/0a867d97c67c92cd38ac0c2c45e1894a","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/145990195","isVote":1,"tweetType":1,"viewCount":640,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":148092265,"gmtCreate":1625897516457,"gmtModify":1703750689434,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Looking forward to coming months.","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Looking forward to coming months.","text":"$BlackBerry(BB)$Looking forward to coming months.","images":[{"img":"https://static.tigerbbs.com/35442be970d8bfa12a797561c059f1f7","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/148092265","isVote":1,"tweetType":1,"viewCount":454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":143435481,"gmtCreate":1625807988343,"gmtModify":1703748986662,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>It is just a temporary setback.","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>It is just a temporary setback.","text":"$BlackBerry(BB)$It is just a temporary setback.","images":[{"img":"https://static.tigerbbs.com/637f76505988242e6e17857b32c2a0cc","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/143435481","isVote":1,"tweetType":1,"viewCount":610,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576032131769827","authorId":"3576032131769827","name":"X.X","avatar":"https://static.tigerbbs.com/76e3e933986368b39ca6e747f121516b","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3576032131769827","idStr":"3576032131769827"},"content":"your price still ok","text":"your price still ok","html":"your price still ok"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":164978241,"gmtCreate":1624168986383,"gmtModify":1703830059089,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"like and comment pls. thank you","listText":"like and comment pls. thank you","text":"like and comment pls. thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/164978241","repostId":"1199331995","repostType":4,"isVote":1,"tweetType":1,"viewCount":753,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162403598,"gmtCreate":1624069960614,"gmtModify":1703828135754,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"$BB Stock","listText":"$BB Stock","text":"$BB Stock","images":[{"img":"https://static.tigerbbs.com/e0cc9c3a9341c1326c64e4f70cd53dfc","width":"1125","height":"3699"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162403598","isVote":1,"tweetType":1,"viewCount":641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":166878892,"gmtCreate":1624004193816,"gmtModify":1703826301403,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"please like and comment. thank you","listText":"please like and comment. thank you","text":"please like and comment. thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/166878892","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1,"symbols_score_info":{"ORPH":0.9}},"isVote":1,"tweetType":1,"viewCount":821,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3582009752060633","authorId":"3582009752060633","name":"Biubiu16","avatar":"https://static.tigerbbs.com/96c4ac0381a6e0c6dc10e39f9acfdc6b","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3582009752060633","idStr":"3582009752060633"},"content":"done please comment on my comment","text":"done please comment on my comment","html":"done please comment on my comment"}],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":802467242,"gmtCreate":1627797385486,"gmtModify":1703496042250,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Should I cut my losses? Or should I HODL?&nbsp;","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Should I cut my losses? Or should I HODL?&nbsp;","text":"$BlackBerry(BB)$Should I cut my losses? Or should I HODL?","images":[{"img":"https://static.tigerbbs.com/ba6cc5f488f492c4049cd60142b7c017","width":"1170","height":"2260"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/802467242","isVote":1,"tweetType":1,"viewCount":814,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576094392273863","authorId":"3576094392273863","name":"Hengheng","avatar":"https://community-static.tradeup.com/news/3c7203a9a2725203dad785f749cf13c8","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3576094392273863","idStr":"3576094392273863"},"content":"hold it. add more when drop.. good prospect company.. salt fish has turn ard. buy for future.?","text":"hold it. add more when drop.. good prospect company.. salt fish has turn ard. buy for future.?","html":"hold it. add more when drop.. good prospect company.. salt fish has turn ard. buy for future.?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":166878892,"gmtCreate":1624004193816,"gmtModify":1703826301403,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"please like and comment. thank you","listText":"please like and comment. thank you","text":"please like and comment. thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/166878892","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1,"symbols_score_info":{"ORPH":0.9}},"isVote":1,"tweetType":1,"viewCount":821,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3582009752060633","authorId":"3582009752060633","name":"Biubiu16","avatar":"https://static.tigerbbs.com/96c4ac0381a6e0c6dc10e39f9acfdc6b","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3582009752060633","idStr":"3582009752060633"},"content":"done please comment on my comment","text":"done please comment on my comment","html":"done please comment on my comment"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164978241,"gmtCreate":1624168986383,"gmtModify":1703830059089,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"like and comment pls. thank you","listText":"like and comment pls. thank you","text":"like and comment pls. thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/164978241","repostId":"1199331995","repostType":4,"isVote":1,"tweetType":1,"viewCount":753,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143435481,"gmtCreate":1625807988343,"gmtModify":1703748986662,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>It is just a temporary setback.","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>It is just a temporary setback.","text":"$BlackBerry(BB)$It is just a temporary setback.","images":[{"img":"https://static.tigerbbs.com/637f76505988242e6e17857b32c2a0cc","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/143435481","isVote":1,"tweetType":1,"viewCount":610,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576032131769827","authorId":"3576032131769827","name":"X.X","avatar":"https://static.tigerbbs.com/76e3e933986368b39ca6e747f121516b","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3576032131769827","idStr":"3576032131769827"},"content":"your price still ok","text":"your price still ok","html":"your price still ok"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":812056632,"gmtCreate":1630542823926,"gmtModify":1676530334280,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Looking better by the day","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Looking better by the day","text":"$BlackBerry(BB)$Looking better by the day","images":[{"img":"https://static.tigerbbs.com/08bb7aa78f8844125c2cd636f7ecb967","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/812056632","isVote":1,"tweetType":1,"viewCount":832,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":179853472,"gmtCreate":1626506638696,"gmtModify":1703761285304,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Trust in BB!&nbsp;","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Trust in BB!&nbsp;","text":"$BlackBerry(BB)$Trust in BB!","images":[{"img":"https://static.tigerbbs.com/197ff3aed4d99406f11ec248b70372c2","width":"1170","height":"2260"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/179853472","isVote":1,"tweetType":1,"viewCount":636,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":145990195,"gmtCreate":1626185143717,"gmtModify":1703755078273,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>Come on!","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>Come on!","text":"$Exela Technologies, Inc.(XELA)$Come on!","images":[{"img":"https://static.tigerbbs.com/0a867d97c67c92cd38ac0c2c45e1894a","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/145990195","isVote":1,"tweetType":1,"viewCount":640,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":148092265,"gmtCreate":1625897516457,"gmtModify":1703750689434,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Looking forward to coming months.","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Looking forward to coming months.","text":"$BlackBerry(BB)$Looking forward to coming months.","images":[{"img":"https://static.tigerbbs.com/35442be970d8bfa12a797561c059f1f7","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/148092265","isVote":1,"tweetType":1,"viewCount":454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":162403598,"gmtCreate":1624069960614,"gmtModify":1703828135754,"author":{"id":"3582539967940651","authorId":"3582539967940651","name":"A3_tothemoon","avatar":"https://static.tigerbbs.com/504f0d6cf91210823ec54c41e8a2c52c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582539967940651","idStr":"3582539967940651"},"themes":[],"htmlText":"$BB Stock","listText":"$BB Stock","text":"$BB Stock","images":[{"img":"https://static.tigerbbs.com/e0cc9c3a9341c1326c64e4f70cd53dfc","width":"1125","height":"3699"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162403598","isVote":1,"tweetType":1,"viewCount":641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}